In clinical studies, significant weight loss was observed around the 24-week mark, with continued progress through 48 weeks
HaloTag forms an intramolecular disulfide
In terms of direct cardiovascular observations from trial data, retatrutide has been associated with modest, dose-dependent increases in resting heart rate , a finding also observed with other GLP-1 receptor agonists (as reflected in the Summary of Product Characteristics for semaglutide and tirzepatide)
Common Side Effects The most frequently reported side effects are injection site reactions
While it can be reversed with reduced alcohol intake, continued drinking can make it more severe with time
The interest in medications like Mounjaro, Wegovy and Ozempic shows no sign of abating, with access and take-up increasing